PM Roble meets with President of Djibouti

Prime Minister of Somalia H.E Mohamed Hussain Roble met today on Wednesday with the President of Djibouti H.E Ismail Omar Guelleh at the Presidential Palace in Djibouti, SONNA reported.

PM Roble and President Guelleh discussed strengthen bilateral relations between the two brotherly nations.

Prime Minister Roble thanked President Guelleh for his important role in bringing peace and stability to Somalia.

Source: Somalia National News Agency

Freelance Journalist Accredited to The Associated Press Detained in Ethiopia

A freelance video journalist accredited to The Associated Press in Ethiopia has been detained by police in the capital, Addis Ababa, the news organization said Wednesday.

Amir Aman Kiyaro was detained under the country’s new war-related state of emergency powers on November 28 after returning home from a reporting trip. He has not been charged.

Officials with the Ethiopian Media Authority, the prime minister’s office, the Foreign Ministry and other government offices have not responded to repeated requests from the AP for information about him since his detention.

State media on Wednesday reported his detention, citing federal police, and said he was accused of “serving the purposes” of a terrorist group by interviewing it. The report said local journalists Thomas Engida and Addisu Muluneh also were detained.

Federal police inspector Tesfaye Olani told state media that the journalists violated the state of emergency law and Ethiopia’s anti-terrorism law and the violations could lead to seven to 15 years behind bars.

In a statement, AP Executive Editor Julie Pace urged that Kiyaro be freed: “The Associated Press is extremely concerned that AP freelancer Amir Aman Kiyaro has been detained by the Ethiopian government, accused of promoting terrorism. These are baseless allegations. Kiyaro is an independent journalist who has done important work in Ethiopia on all sides of the conflict. We call on the Ethiopian government to release Kiyaro immediately.”

She said the AP until now had chosen to keep the case out of the public eye while the news organization worked on potential diplomatic channels.

Ethiopia’s government in November declared a state of emergency, which includes sweeping powers of detention, after a year of war as rival forces from the country’s northern Tigray region in collaboration with the Oromo Liberation Army moved closer to the capital. The government this year declared both the Tigray forces and the OLA as terrorist groups.

Tens of thousands of people have been killed in the war that erupted in November 2020. The Tigray forces say they are pressuring the government to lift a deadly blockade on their region but also want Prime Minister Abiy Ahmed to step aside. Mediation efforts by the United States and African Union for a cease-fire have made little progress.

Kiyaro has covered both sides of the war this year for the AP, including groundbreaking reporting on the alleged mass killings by Tigray forces in the community of Chenna Teklehaymanot after the fighters in recent months moved into Ethiopia’s neighboring Amhara region.

In late November, the country’s state of emergency command sought to restrict media reporting on the war, forbidding the sharing of nonofficial information on “military-related movements, battlefront results and situations.” Foreign media have been barred from Tigray for much of the war, with communications links severed.

The government-created Ethiopian Human Rights Commission on Wednesday said it was monitoring the situation of four other local journalists detained in recent weeks.

Last month, it said it was alarmed by the conditions of the detentions of perhaps thousands of people who have been swept up under the state of emergency. It urged authorities to immediately release people detained without “evidence establishing reasonable grounds for suspicion.”

Spokespeople for the commission did not immediately respond to a request for comment on Kiyaro.

“Ethiopia has again become one of the worst jailers of journalists in sub-Saharan Africa,” the Committee to Protect Journalists said in a statement last week, describing the media environment as “hostile” three years after the prime minister took office and his government freed journalists as part of sweeping political reforms that have since been eroded.

Source: Voice of America

African Leaders Call for More Investment in Healthcare

African leaders have called on governments across the continent to invest more in healthcare to fight the coronavirus and future pandemics. The appeal came as the Africa Centers for Disease Control and Prevention and the African Union this week held the first Conference on Public Health in Africa.

Addressing the virtual meeting of African health workers and experts, Rwandan President Paul Kagame said governments could no longer ignore public health investment as the continent grapples with the COVID-19 pandemic.

“There needs to be renewed commitment by government and national parliaments to increase domestic financing for health in Africa. This has been a priority for the African Union for several years but progress has not been fast enough. We cannot continue to rely on external funding for something so important for our future,” he said.

Twenty years ago in Abuja, Nigeria, African governments agreed to allocate 15% of their budgets to health care. Only two countries, Rwanda and South Africa, met the target.

Africa has seen economic growth in the past few years but spending by governments on health has rarely increased.

Health experts blame the lack of healthcare spending on low GDP growth, tax collections, and competing priorities.

An Afrobarometer survey showed 46% of African citizens across 36 countries opposed paying more taxes to be used to improve healthcare.

Across Africa, most health facilities are concentrated in urban areas, effectively cutting off millions from accessing advanced medical assistance.

John Nkengasong, the head of the Africa Centers for Disease Control and Prevention, said the continent needs a new approach to raise health investment.

“You all heard from our various leaders, political leaders, call for a new public health order that hinges on four things: strengthening public health institutions, workforce, expanding manufacturing on both vaccines, diagnostic and therapeutic, a respectful action-oriented partnership, which is all underpinned by the need to invest ourselves in supporting this domestic financing so that we can achieve these four goals,” he said.

African Union Commission Chairman Mousa Faki Mahamat pledged to support the development of health care systems that can deal with future challenges.

“I would like to assure you today that African Union Commission stands firm in our resolve to bolster manufacturing capacity for the vaccine, diagnostic and therapeutics to build resilient health systems capable of detecting future health threats, and to build a finance mechanism that allows member states to respond efficiently and effectively to health needs of the continent,” he said.

According to the Brookings Institute, Africa needs funding models that encourage domestic resource mobilization and prioritization of health.

For example, in 2019 Nigeria signed a $75 million financing agreement with the Bill and Melinda Gates Foundation to strengthen the country’s primary health care provision fund.

Africa’s virtual conference on public health ends Thursday.

Stay Calm, Don’t Panic, Says South African Doctor

The head of the South African Medical Association says there is a major difference between the delta and omicron variants of the coronavirus and warns politicians against hyping the threat from the new strain.

Dr. Angelique Coetzee criticized Tuesday what she described as the “over-reaction” to the heavily mutated omicron variant by some European governments and cited Britain’s Boris Johnson, who she accused of creating “hysteria” about the new strain.

On Tuesday, the House of Commons approved the reimposition of pandemic restrictions, and the introduction of some new ones, because of rising omicron cases in the country, although Johnson faced a major rebellion by a third of his parliamentary party and relied on opposition parties for the vote.

Coetzee was one of the first medical practitioners in the world to raise the alarm about the new variant. Its genomic data was sequenced last month by scientists in Hong Kong, Botswana as well as South Africa. The emergence has contributed to pandemic alarm in Europe, where governments are already battling the delta strain and are racing to reimpose restrictions.

Coetzee told Britain’s Sky News that delta was heart-breaking and that her patients who contracted it were “extremely, extremely sick” and when opening the door to them “you just knew they were in trouble,” she explained.

But nearly a month into the omicron wave in South Africa, she says she has not seen similar grim scenes and that her omicron patients are suffering much milder symptoms. Apart from one, who had HIV and other comorbidities, none have died.

The British government’s medical advisers are predicting one million omicron infections by the end of the month, and although South Africa is seeing tens of thousands of new cases daily.

Coetzee cautions calm, saying Britain and other European countries are much better vaccinated than South Africa and in a better position to battle it. “Even if you get breakthrough infections, it’s mild cases,” she added, saying she understands the need to take precautionary measures but says, “don’t hype it up.”

Some scientists disagree with Coetzee.

The chief executive of Britain’s Health Security Agency told lawmakers Wednesday that omicron “is probably the most significant threat since the start of the pandemic.”

Dr. Jenny Harries said the new variant was much more transmissible than delta and the rapid spread of omicron would lead to a “staggering” number of COVID cases over the next few days. She delivered a series of dire warnings about the country’s health care system, although she added it was probably too early to tell how serious the scale of increasing infections across the world would turn out to be.

“The difficulty is that the growth of this virus, it has a doubling time which is shortening, i.e., it’s doubling faster, growing faster,” she said.

Governments across Europe are closely observing events unfolding in Britain for a sense of what may lie ahead for them as omicron spreads, and they are worried that reinfection rates from omicron are much higher than has been seen with earlier variants.

Restrictions and penalties

More countries are adopting restrictions. Italy this week required negative tests from vaccinated visitors to the country. Portugal has a similar measure in place. Many European countries have a virtual lockdown for the unvaccinated and are scrambling to increase vaccine booster programs. And more governments, including Germany’s, are proposing or considering mandatory vaccines.

Austria and Italy already plan to impose hefty fines on eligible people who do not get vaccinated.

People over 65 years old in France will be under effective lockdown from Wednesday, if they have not received a third vaccine booster dose.

France’s health pass will no longer be valid for the elderly who have not received a third dose, barring those who have not been boosted from visiting restaurants or cafes or taking intercity trains. They will also be prohibited from visiting cultural venues like cinemas or museums.

European Commission President Ursula von der Leyen warned Wednesday the European Union faces a double challenge, with a massive increase of delta cases in recent weeks and the threat of omicron looming. “We’re seeing an increasing number of people falling ill, a greater burden on hospitals and unfortunately, an increase in the number of deaths,” she told European Parliament lawmakers.

“And what I’m concerned about is that we now [are] seeing the new variant omicron on the horizon, which is apparently even more infectious,” she added.

But as governments go into overdrive, some epidemiologists and virologists are echoing Angelique Coetzee. Professor Tim Spector, the head of Genetic Epidemiology at King’s College, London, says the “majority of symptoms are just like a common cold, so we’re talking about headaches, sore throat, runny nose, fatigue, and things like sneezing.” He added: “So, things like fever and cough and loss of smell are now actually in the minority of the symptoms that we’re seeing.”

Earlier this week, the first major study published into the new variant also suggested illness from omicron is less severe than from delta. The study of 78,000 omicron cases in South Africa found the risk of hospitalization is 29% lower compared with the Wuhan strain, and 23% lower than with delta. Far fewer people have been needing intensive care. Just 5% of omicron cases have been admitted to intensive care units compared to 22% of delta patients, the study shows.

The data for the study was compiled by Discovery Health, South Africa’s largest private health insurer, and the South Africa Medical Research Council. It noted omicron can evade vaccines more than earlier strains, but the study found vaccines are still holding up well, although there were high numbers of breakthrough infections in people who had been vaccinated.

Vaccine effectiveness against infection dropped from 80% to 33%, according to the study, but offered 70% protection against hospital admission. Boosters may also mitigate the reduction in vaccine effectiveness, according to the study. Some European scientists have cautioned, though, against reading too much into the South African study, saying that South Africa’s population is much younger and that demographic differences could alter medical outcomes.

Source: Voice of America

Merck Collaborates with Innovative Biotech to Support Establishment of First Vaccine Production Facility in Nigeria

– Supports West African pandemic readiness program

– Accelerates self-sufficient vaccine development and manufacturing in West Africa

LAGOS, Nigeria, Dec. 14, 2021 /PRNewswire/ — Merck, a leading science and technology company, today announced that it has signed an agreement with biotechnology company Innovative Biotech (IB) to design the manufacturing process for the first vaccine production facility in Nigeria.

Merck collaborates with Innovative Biotech to design the manufacturing process for the first vaccine production facility in Nigeria. Pictured left to right: Dr. Jose M Galarza, CEO, TechnoVax; Mr. Sohal Shah, Strategic and Financial Adviser, TechnoVax; Dr. Simon Agwale, CEO, Innovative Biotech; Dr. Andrew Bulpin, Head of Process Solutions, Life Science business sector of Merck KGaA, Darmstadt, Germany.

“We are committed to expanding access to life-saving and life-enhancing therapies to patients across the world and this collaboration is a testament to that commitment,” said Andrew Bulpin, Head of Process Solutions, Life Science business sector at Merck.  “We are proud to provide the technical support and expertise that could help enable the first vaccine facility in Nigeria and localize vaccine development in the West Africa region.”

This collaboration is part of the West African pandemic readiness program, which aims to localize vaccine development in the African nations. The first phase of this integrated partnership focuses on designing the fill and finish facility, incorporating the company’s Mobius® single-use technology, while the second phase will focus on enabling continuous manufacturing.

“By leveraging the company’s facility design expertise, we’ll be able to build the first vaccine production facility in Nigeria and manufacture high-quality and affordable vaccines locally,” said Simon Agwale, CEO of Innovative Biotech.

Innovative Biotech’s licensor, TechnoVax, is developing a virus-like-particle (VLP)-based vaccine to target variants of Covid-19. Provisional results from the preclinical studies of the VLP-based vaccine have shown promise for virus neutralization. Technovax is a 2019 recipient of Life Science’s Advance Biotech Grant for developing a virus-like particle platform that facilitates the development and production of a range of vaccines targeting the prevention of respiratory diseases, hemorrhagic fevers, immunodeficiency and cancers.

The Life Science business sector has been supporting Innovative Biotech’s effort with its BioReliance® testing services, technical transfer support and single-use facility design. This partnership showcases the company’s commitment to supporting the building of manufacturing capabilities in the Middle East and Africa.

About Merck
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck generated sales of € 17.5 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.

Photo – https://mma.prnewswire.com/media/1707650/Merck_Collaborates_With_Innovative_Biotech.jpg